241
Views
12
CrossRef citations to date
0
Altmetric
Review

The recent application of 3D-QSAR and docking studies to novel HIV-protease inhibitor drug discovery

, , &
Pages 1095-1109 | Received 03 Dec 2019, Accepted 20 May 2020, Published online: 21 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fei Xiong, Lu Chen, Yan-jun Zhang, Yi-ren Zhu, Chen Sun, Chao Ma, Shuai-jun Zhang & Zhong-hua Wang. (2023) Molecular Modeling and Docking Studies of 2,4,5-Trisubstituted Pyrimidines as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Polycyclic Aromatic Compounds 43:9, pages 7870-7889.
Read now
Ikponmwosa Owen Evbuomwan, Omokolade Oluwaseyi Alejolowo, Tobiloba Christiana Elebiyo, Charles Obiora Nwonuma, Oluwafemi Adeleke Ojo, Evelyn Uwa Edosomwan, Joy Ifeyinwa Chikwendu, Nwanneka Victoria Elosiuba, Justina Chimezie Akulue, Festus Ayorinde Dogunro, Damilare Emmanuel Rotimi, Omorefosa Osarenkhoe Osemwegie, Adebola Busola Ojo, Olusegun George Ademowo, Oluyomi Stephen Adeyemi & Olarewaju Michael Oluba. (2023) In silico modeling revealed phytomolecules derived from Cymbopogon citratus (DC.) leaf extract as promising candidates for malaria therapy. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Shuo Wang, Yujie Ren, Zhao Wang, Xiangyi Jiang, Shujing Xu, Xujie Zhang, Shujie Zhao, Waleed A Zalloum, Xinyong Liu & Peng Zhan. (2022) The current progress in the use of boron as a platform for novel antiviral drug design. Expert Opinion on Drug Discovery 17:12, pages 1329-1340.
Read now

Articles from other publishers (9)

Min Li, Yayao Wang, Jianren Xu, Xiu Zhang & Zhaojun Wei. (2023) Deciphering the toxicity mechanism of haloquinolines on Chlorella pyrenoidosa using QSAR and metabolomics approaches. Ecotoxicology and Environmental Safety 257, pages 114943.
Crossref
Yan Tuo, Yuelu Tang, Yongxin Yu, Haoran Liang, Bin Huang, Shan Geng & Yuanqiang Wang. (2023) Structural investigation of Keap1–Nrf2 protein–protein interaction (PPI) inhibitors for treating myocarditis through molecular simulations. New Journal of Chemistry 47:18, pages 8524-8537.
Crossref
Juntao Li, Yue Wu, Xinxin Yu, Xinyu Zheng, Jiechen Xian, Senjie Li, Wanyin Shi, Yun Tang, Zhe-Sheng Chen, Guixia Liu, Shen Yao, Jian Xu & Xiangwei Zheng. (2022) Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitors. Chinese Medicine 17:1.
Crossref
Arti GuptaViney LatherDushyanth R. VennapuSandeep KumarMallikarjun. B.P.Neerupma DhimanArchana Sharma. (2022) 3D-QSAR, E-pharmacophore and molecular docking to explore substituted sulfonamides as carbonic anhydrase inhibitors in epilepsy. Research Journal of Pharmacy and Technology, pages 5521-5528.
Crossref
Marko Popovic. (2022) Biothermodynamics of Viruses from Absolute Zero (1950) to Virothermodynamics (2022). Vaccines 10:12, pages 2112.
Crossref
Yan-Jun Zhang, Lu Chen, Jie Xu, Hui-Fang Jiang, Yi-Ren Zhu, Zhong-Hua Wang & Fei Xiong. (2022) Evaluation of novel HIV-1 protease inhibitors with DRV-resistance by utilizing 3D-QSAR molecular docking and molecular dynamics simulation. New Journal of Chemistry 46:45, pages 21885-21897.
Crossref
Shasank S. Swain & Tahziba Hussain. (2022) Combined Bioinformatics and Combinatorial Chemistry Tools to Locate Drug‐Able Anti‐TB Phytochemicals: A Cost‐Effective Platform for Natural Product‐Based Drug Discovery. Chemistry & Biodiversity 19:11.
Crossref
Vladimir R. Vukic, Dajana V. Vukic, Goran Benedekovic, Vesna Kojic & Velimir Popsavin. (2022) (–)-cleistenolide and its Analogs as New Potential Antitumor Compounds Against PC-3 Cells. Pharmaceutical Chemistry Journal 56:5, pages 619-626.
Crossref
Yu Chen, Fukuan Du, Liyao Tang, Jinrun Xu, Yueshui Zhao, Xu Wu, Mingxing Li, Jing Shen, Qinglian Wen, Chi Hin Cho & Zhangang Xiao. (2022) Carboranes as unique pharmacophores in antitumor medicinal chemistry. Molecular Therapy - Oncolytics 24, pages 400-416.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.